Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EpSSG RMS 2005
NCT00339118Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 4 trial of doxorubicin, cyclophosphamide in rhabdomyosarcoma (RMS), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
doxorubicincyclophosphamide
03
Conditions
rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT00339118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00339118.